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ABSTRACT
Specific guanine-rich regions in human genome
can form higher-order DNA structures called
G-quadruplexes, which regulate many relevant
biological processes. For instance, the formation
of G-quadruplex at telomeres can alter cellular
functions, inducing apoptosis. Thus, developing
small molecules that are able to bind and sta-
bilize the telomeric G-quadruplexes represents
an attractive strategy for antitumor therapy. An
example is 3-(benzo[d]thiazol-2-yl)-7-hydroxy-8-((4-
(2-hydroxyethyl)piperazin-1-yl)methyl)-2H-chromen-
2-one (compound 1), recently identified as potent
ligand of the G-quadruplex [d(TGGGGT)]4 with
promising in vitro antitumor activity. The experi-
mental observations are suggestive of a complex
binding mechanism that, despite efforts, has defied
full characterization. Here, we provide through
metadynamics simulations a comprehensive un-
derstanding of the binding mechanism of 1 to the
G-quadruplex [d(TGGGGT)]4. In our calculations, the
ligand explores all the available binding sites on the
DNA structure and the free-energy landscape of the
whole binding process is computed. We have thus
disclosed a peculiar hopping binding mechanism
whereas 1 is able to bind both to the groove and
to the 3’ end of the G-quadruplex. Our results fully
explain the available experimental data, rendering
our approach of great value for further ligand/DNA
studies.
INTRODUCTION
Nucleic acids contain the genetic information essential for
life. In particular, their sequence encodes vital instructions
for the cell, such as replication and transcription. The de-
oxyribonucleic acid (DNA) usually assumes a standard
double helix conformation (1). However, in the last decades,
DNA has been found to adopt several alternative confor-
mations having specific roles during cell life. Among these
are G-quadruplexes (2), that are stacks of G-quartets, also
known as G-tetrads, formed by four guanines hydrogen
bonded to each other (Figure 1A) (3). These structures
are found in important guanine-rich regions of the human
genome, such as gene promoters and telomeres (4–9). In
particular, telomeres are ensembles of proteins and noncod-
ingDNA that protect chromosomes termini fromunwanted
events, such as recombination, degradation, and end-to-end
fusion. Furthermore, they prevent chromosomes termini to
be recognized as DNA double strand breaks (10,11). Thus,
they are crucial for cell lifespan. In normal cells, telomeric
DNA shortens at each cell cycle and this eventually leads
to senescence or apoptotic cell death (12). In tumor cells in-
stead, telomere length ismaintained thanks either to a finely
tuned mechanism involving the telomerase enzyme (13) or
through recombination events between telomeres, a phe-
nomenon known as the alternative lengthening of telomeres
(ALT) mechanism (14).
In 1991, Zahler et al. found that folding of telomeric
DNA into a G-quadruplex structure inhibits in vitro telom-
erase activity (15), andmore recently also theALT cells have
been found to be particularly sensitive to the presence of G-
quadruplexes (14). Furthermore, in the last few years, the
formation ofG-quadruplex structures at telomeres has been
found to activate the fast DNA-damage response pathway,
inducing rapid apoptosis (16,17). Consequently, molecules
able to bind and stabilize G-quadruplex structures can se-
*To whom correspondence should be addressed. Tel: +39 081 678 641; Fax: +39 081 678 107; Email: vittoriolimongelli@gmail.com
C© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
5448 Nucleic Acids Research, 2014, Vol. 42, No. 9
lectively alter telomeric functions in cancer cells, thus lead-
ing to a marked inhibition of tumor growth (18,19).
To date, many G-quadruplex selective ligands with po-
tential antitumor activity have been developed (20–27).
Most of them, called end-stackers, are usually polyaromatic
molecules that bind to the ends of the G-tetrads, such as
BRACO-19 (28), RHPS4 (29,30), and telomestatin (31,32).
Unfortunately, none of these ligands passed to clinical tri-
als because of their poor drug-like properties and selectiv-
ity. At variance with end-stackers, another class of ligands
can bind to the grooves of the G-quadruplexes. These com-
pounds, known as groove binders, can be more selective
than end-stackers by recognizing the specific groove confor-
mations of different DNA structures. However, despite ef-
forts in developing potent and selective groove binders, only
few examples have been to date reported in literature (33–
38).
In this framework, a number of structural and compu-
tational studies have been performed targeting the telom-
ericG-quadruplex [d(TGGGGT)]4. Although this structure
is not a representative human telomeric G-quadruplex, it
is often used as a working model for its structural sim-
plicity. In fact, it has a 4-fold symmetry, with all paral-
lel strands, four identical grooves, and three monovalent
cations at the center of the guanines stacks (Figure 1A
and B) (39). In particular, [d(TGGGGT)]4 has been used
to identify ligands able to bind both the groove (33,34,36–
38) and the stacking surfaces of G-quadruplex (40). One
recent example is a structure-based virtual screening cam-
paign that led to the identification of compound 1 (36),
which features a 3-(benzo[d]thiazol-2-yl)-2H-chrom-en-2-
one aromatic scaffold with the positively charged N-(2-
hydroxyethyl)piperazinyl branch (Figure 1C). This ligand
has a marked binding affinity toward [d(TGGGGT)]4 as re-
vealed by nuclear magnetic resonance (NMR) experiments
(36). Furthermore, isothermal titration calorimetry (ITC)
experiments showed that 1 binds to [d(TGGGGT)]4 more
tightly than distamycin A (41), that is the reference com-
pound among the G-quadruplex groove binders. These bio-
physical experiments have been complemented by in vitro
assays showing that 1 is able to induce DNA damage and
cell-cycle arrest in specific cancer cell lines (42).
Despite these efforts, a comprehensive elucidation of the
way this compound interacts with DNA is still lacking. In
fact, NMR data showed the involvement in the ligand bind-
ing of residues both at the groove and at the end of theDNA
structure. These observations are suggestive of a complex
binding mechanism that was only partially described by the
docking calculations where compound 1 was found to bind
at the center of the groove (41). Thus, a deeper insight is nec-
essary where considering the full DNA flexibility and the
solvent effect during the exploration of the sites available
for the ligand binding. These investigations are essential for
an exhaustive elucidation of the ligand binding mechanism
and to provide the molecular information useful for drug
design studies.
With this in mind, we decided to investigate at atom-
istic level the binding mechanism of compound 1 to its tar-
get DNA [d(TGGGGT)]4. Unfortunately, the ligand bind-
ing and unbinding processes are typically a long time-scale
event, in the order of microseconds to milliseconds, difficult
to sample with standard techniques, such as molecular dy-
namics (MD). Thus, the use of enhanced-samplingmethods
is recommended. Among the emerging techniques, meta-
dynamics (43) has been successful in describing long time-
scale biological events and complex ligand binding mecha-
nisms, allowing also to reconstruct the free-energy surface
(FES) of the investigated processes (44–48). In the nucleic
acids research field, metadynamics has been successfully
used to study the unbinding process of small duplex DNA
intercalators (49,50), and more recently that of a drug from
a protein–duplex DNA complex (51). However, so far this
technique has never been applied to investigate the binding
of a ligand to a G-quadruplex DNA.
Here, we present a fully unbiased binding study of com-
pound 1 to theG-quadruplex [d(TGGGGT)]4 during which
no structural information on ligand binding is used. To this
goal, we performed well-tempered metadynamics simula-
tions (52), which enhance the sampling allowing an exhaus-
tive exploration of all the possible ligand binding sites on
the DNA structure in an affordable computational time.
The whole binding event is thus described taking fully into
account the DNA flexibility together with the presence of
explicit solvent and ions. At the end of the simulation,
we reconstructed the free-energy landscape of the bind-
ing event together with an accurate estimate of the abso-
lute ligand/DNAbinding free energy. These calculations al-
lowed us identifying themain interaction sites of compound
1 and revealing the lowest energy ligand binding modes.
In particular, we show that compound 1 interacts with G-
quadruplex through a hopping binding mechanism pass-
ing from one DNA site to the other. This process is ruled
by specific ligand/DNA interactions, such as hydrophobic
and polar contacts between the ligand aromatic scaffold
and the nucleobases, and salt–bridge interactions between
the ligand charged chain and the phosphate groups of the
G-quadruplex. Compound 1 shows two lowest free-energy
binding modes, being able at the same time to bind to the
groove and to the 3’ end of the G-quadruplex. These find-
ings are of great value for the structural optimization of
compound 1 and for de-novo rational drug design, since dif-
ferent binding modes to G-quadruplex can be exploited to
develop new ligands.
Our study also reveals that DNA flexibility plays an im-
portant role during the ligand binding and water molecules
contribute to stabilize the most relevant ligand binding
poses. The results obtained are in agreement with data com-
ing from NMR experiments and allow us to interpret fea-
tures of the experiments that were previously unclear. For
instance, we show that the T6 residue is involved in the lig-
and binding to the 3’ end of DNA, thus explaining the ex-
perimental observations. These findings render our protocol
of great value for further investigations on ligand/DNA in-
teraction that can assist drug discovery strategies to develop
potent and selective DNA binders.
MATERIALS AND METHODS
Molecular docking
Molecular docking calculations of 1 in the crystal struc-
ture of theG-quadruplex [d(TGGGGT)]4 (PDB code: 1s45)
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(39) were carried out using the AutoDock4.2 (AD4) soft-
ware package (53) as implemented through the graphical
user interface AutoDockTools (ADT 1.5.4) (54). The lig-
and tridimensional structure was generated with the Mae-
stro Build Panel (55), and its protonation state at physio-
logical pH (7.4) was assigned using Epik (56). The target
DNA structure was prepared through the Protein Prepa-
ration Wizard of the graphical user interface Maestro 9.3
(55). Water molecules were removed, hydrogen atoms were
added and the co-crystallized Tl+ ions were replaced with
the more physiologically relevant K+ ions. Ligand and re-
ceptor structures were converted to AD4 format files using
ADT and the Gesteiger–Marsili partial charges were then
assigned to the ligand and nucleic acid atoms. In order to
allow the ligand to explore the whole conformational space,
the docking area was centered on the Cartesian coordinates
of the center of mass of the G-quadruplex structure and de-
fined by a box large enough to include the whole macro-
molecule. Thus, grid points of 90 × 90 × 90 with a 0.375
A˚ spacing were calculated around the docking area for all
the ligand atom types using AutoGrid4.2. Thus, 100 sep-
arate docking calculations were performed. Each docking
run consisted of 10 millions energy evaluations using the
Lamarckian genetic algorithm local search method. Oth-
erwise default docking parameters were applied. Docking
conformations were clustered on the basis of the root mean
square deviation (rmsd) between the Cartesian coordinates
of the ligand atoms (cutoff = 2.0 A˚) and were ranked based
on the AutoDock scoring function (53). Finally, the lowest
energy binding pose provided by preliminary docking cal-
culations was selected as the starting conformation for the
subsequentmetadynamics simulation. However, it is impor-
tant to underline that the ligand starting conformation does
not affect the final results of a well-converged metadynam-
ics simulation, thus we can arbitrarily choose whatever pose
predicted by the docking program as starting structure.
Additional docking calculations using the DNA confor-
mation of the free-energyminimumAa obtained frommeta-
dynamics simulation were performed applying the same
protocol.
Molecular docking calculations on duplex DNA were
performed using the structure of the B-DNA dodecamer
[d(CGCGAATTCGCG)]2 (PDB code: 1bna) (57), which
has been reported to be recognized by 1 (42).
Molecular dynamics
All the simulations were carried out using the standard
parm99 Amber force field for nucleic acids modified using
the recently developed parmbsc0 parameters (58–60). The
NAMD 2.8 code (61) combined with the external plugin
PLUMED 1.2.2 (62) was used to perform the simulations.
The 1/[d(TGGGGT)]4 complex was solvated in a 12.0 A˚
layer cubic water box using the TIP3P water model param-
eters (63). K+ cations were used to neutralize the system,
with three of these ions placed at the center of theG-tetrads.
During the simulations, distance constraints were applied
between these ions and their coordinating guanine oxygens.
Further 11 K+ and 11 Cl− ions were added to reproduce
the NMR experimental conditions of 70 mM KCl. A cut-
off of 10 A˚ was used for short-range interactions. The long-
range electrostatic interactions were computed by means of
the particle mesh Ewald method using a 1.0 A˚ grid spac-
ing in periodic boundary conditions. The SHAKE algo-
rithm was applied to constraint bonds involving hydrogen
atoms, with a 2 fs integration time step. Amber charges were
applied to the DNA and water molecules, whereas ligand
charges were computed using the restrained electrostatic
potential (RESP) fitting procedure (64). The ESP was first
calculated by means of the Gaussian package (65) using a
6–31G* basis set at Hartree–Fock level of theory, and then
the RESP charges were obtained by a two-stages fitting pro-
cedure usingAntechamber (66). The systemwas thus equili-
brated through 10 nsMD in the isothermal–isobaric ensem-
ble (NPT) at 1 atm and 300 K before running metadynam-
ics simulations in the canonical isothermal-isochoric (NVT)
ensemble.
Standard MD simulations to verify the stability of the
metadynamics poses were performed in the NPT ensemble
at 1.0 atm and 300 K.
Metadynamics
The estimationF(s,t) at time t of the FESF(s) as a function
of the collective variable (CV) s was determined by meta-
dynamics (43) in its well-tempered variant (52), using the
following formula:
F(s, t) = −T + T
T
V(s, t), ()
whereV(s,t) is the bias potential added to the system and
T is the temperature of the simulation. T is the difference
between the temperature of the CV and that of the simula-
tion. The bias potential is made up by the sum of the Gaus-
sians deposited along the trajectory of the CV. The explo-
ration of the CV space can be increased by tuning T. A
Gaussian deposition rate of 0.5 kcal/mol/ps was initially
used and gradually decreased on the basis of the adaptive
bias with aT of 2,700K. TwoCVswere chosen to describe
the different ligand conformations during the metadynam-
ics run: (i) the distance (d) between the center of mass of
[d(TGGGGT)]4 and that of the 3-benzothiazol-2-yl-chrom-
en-2-one scaffold of compound 1; (ii) the dihedral angle
(torsion − ϕ) defined by the major inertia axis of the lig-
and and that ofDNA (Supplementary Figure S1A and Sup-
plementary Table S1). Gaussian widths of 0.23 A˚ and 0.05
rad were used for the d and ϕ CVs, respectively. During the
metadynamics simulations, an upper limit constraint at 27.0
A˚ was applied to the d CV to reduce the conformational
space to explore in the fully unbound state.
The reweighting procedure
To identify the main ligand binding sites on the G-
quadruplex [d(TGGGGT)]4 together with the lowest energy
ligand binding conformations, we applied a recently devel-
oped reweighting procedure (67). This algorithm allows re-
constructing the Boltzmann distribution relative to CVs dif-
ferent from those biased in the metadynamics run. In fact,
once the metadynamics simulation is converged, using the
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newly computed probability distribution, the FES can be re-
constructed as a function of the newly selected CVs. In the
present case, two CVs were chosen to distinguish the main
ligand binding sites on [d(TGGGGT)]4: (i) the projection
of the center of mass of the 3-benzothiazol-2-yl-chrom-en-
2-one scaffold of compound 1 on the major inertia axis of
the target DNA (projection on axis––POA) and (ii) the dis-
tance of the same center of mass from this axis (distance
fromaxis––DFA) (Figure 3A and Supplementary Table S1).
Finally, to identify the lowest energy ligand binding confor-
mations, the FES was computed as function of (i) the POA
CV described above, and (ii) a torsion CV defined by the
dihedral angle (ψ) between the major inertia axis of the N-
(2-hydroxyethyl)piperazinyl tail of compound 1 and that of
the G-quadruplex (Supplementary Figure S1B and Supple-
mentary Table S1).
All figures were rendered with PyMOL (www.pymol.org)
and Gnuplot.
RESULTS
As discussed before, we used well-tempered metadynamics
to simulate the binding process of 1 to [d(TGGGGT)]4. In
any metadynamics simulations, one is required to define a
set of properly chosen degrees of freedom, called CVs (52),
with whom an adaptive bias is constructed. In such a way,
the binding process can be sampled in a relatively short
computational time, overcoming large free-energy barriers
and reconstructing the FES of the whole binding event
(43,52). The choice of the CVs represents a crucial point
in this kind of simulations, as they should describe the most
relevant slow modes of the investigated process to achieve a
reliable estimation of the free energy (68,69).
In the present study, we used a distance (d) and a dihedral
angle (torsion − ϕ) CV (see ‘Materials and Methods’, Sup-
plementary Figure S1A and Supplementary Table S1). In
particular, we purposely chose for d the distance between
the center of mass of [d(TGGGGT)]4 and that of the 3-
benzothiazol-2-yl-chrom-en-2-one scaffold of compound 1.
In fact, since [d(TGGGGT)]4 presents symmetric binding
sites relative to the center of mass of DNA, this choice as-
signs to these sites the same d values, thus considering them
equivalent during the simulation. In addition to the distance
d, the torsion CV describes the different orientations of the
ligand relative to DNA during the sampling.
A movie showing the exploration of the DNA binding
sites by the ligand during metadynamics simulation can be
found as Movie S1.
The ligand/G-quadruplex binding sites
The whole sampling took ∼1 s of metadynamics simula-
tions. Looking at the FES computed as function of d and
ϕ (Figure 2), one can note that while these CVs take into
account the 4-fold symmetry of the target and they are able
to explore all the binding conformations, they have the dis-
advantage of not being able to discriminate between the dif-
ferent ligand binding modes (see Figure 2 and Supplemen-
tary Discussion for details). Therefore, we decided to recon-
struct the free-energy landscape along different CVs using
the reweighting algorithm of Bonomi et al. (67). This algo-
Figure 1. (A) Top and (B) side view of the crystal structure of the
tetrameric G-quadruplex [d(TGGGGT)]4 (PDB code 1s45). Nucleotides
are shown as sticks colored by atom type and backbone as gray cartoon.
K+ ions are depicted as purple spheres. Hydrogen bonds are represented as
dashed black lines. (C) Chemical structure of compound 1 at physiological
pH 7.4 (see ‘Materials and Methods’).
rithm allows computing the FES as function of CVs differ-
ent from those biased during the metadynamics simulation.
As new CVs, we chose a “POA” and “DFA” CVs, where the
axis is the major inertia axis of the G-quadruplex (see ‘Ma-
terials and Methods’, Figure 3A and Supplementary Table
S1). In such a way, one can discriminate among the different
ligand binding sites. The reweighted FES shows that the lig-
and binds to DNA through a hopping mechanism passing
from one binding site to the other. In particular, two main
free-energy minima, A and B were found, with basin A ap-
proximately 1.5 kcal/mol deeper than B (Figure 3B). In A,
the ligand binds to the groove of the G-quadruplex struc-
ture, while inB compound 1 stacks at the 3’ region of DNA,
thus showing a peculiar dual binding mode. In fact, to the
best of our knowledge, no other G-quadruplex ligand has
a similar behavior and this information might be of great
value for drug design, since one can exploit both binding
modes to develop new ligands. From the FES in Figure 3B,
one can see that the ligand binds preferably to the 3’ end
rather than to 5’. This preference can be explained by the
electrostatic properties of [d(TGGGGT)]4 and in particular
by the electric dipole moment that is oriented toward the 5’
end (see Supplementary Figure S2). The dipole arises from
the different topology at the 3’ and 5’ end. In particular, the
orientation of the negative phosphate groups, which point
toward the 3’ end of the G-quadruplex, favors the binding
of 1 to the 3’ terminus.
The ligand binding modes
Although this FES representation is amarked improvement
over that shown in Figure 2, it does not fully separates the
different ligand binding modes. In fact, a cluster analysis
of basin A and B poses shows a high heterogeneity of lig-
and conformations, suggesting the necessity of using CVs
different from POA and DFA to distinguish the various
ligand binding modes at the groove and at the 3’ end. To
this end, we recomputed the FES as a function of the POA
CV and the torsion CV ψ . In particular, the latter was pur-
posely chosen to distinguish the different orientations of the
N-(2-hydroxyethyl)piperazinyl tail of the ligand relative to
the G-quadruplex axis (see ‘Materials and Methods’, Sup-
plementary Figure S1B and Supplementary Table S1). At
variance with the previously computed FES, now the free-
energy landscape shows three main energy minima, Aa, Ab,
and B (Figure 4A), with the lowest energy minimum Aa
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Figure 2. Representation of the binding FES of 1 to [d(TGGGGT)]4 as function of the distance (d) and dihedral (ϕ) with isosurfaces displayed every 1.5
kcal/mol. The conformations representing the main free-energy minima are shown as insets. One can note that using this FES representation the groove
and the 3’-end binding modes are not unequivocally identified by the free-energy minima and the use of more appropriate CVs is necessary (see the main
text for details). DNA is displayed as gray sticks and cartoon, while the ligand is shown as cyan sticks. K+ ions are depicted as purple spheres. Hydrogen
bonds are highlighted as dashed black lines. Nonpolar hydrogens are omitted for clarity.
Figure 3. (A) Illustration of the “POA” (green arrow) and “DFA”
(red dashed arrow) CVs. (B) Representation of the binding FES of 1 to
[d(TGGGGT)]4 as function of the POA and DFA CVs with the most rep-
resentative ligand binding conformations found at the deepest energy min-
ima A and B. Isosurfaces of 1.5 kcal/mol are used. DNA is displayed as
gray sticks and cartoon, while the ligand is shown as cyan sticks. K+ ions
are depicted as purple spheres. Thymidines and hydrogens are omitted for
clarity.
about 0.9 and 1.4 kcal/mol deeper than Ab and B, respec-
tively. We stress that to obtain the FESs in Figures 3 and 4A
we did not perform a new metadynamics calculation, but
simply represented in a different and more physically trans-
parent way the sampling data obtained using the variables
d and ϕ.
Groove binding
In basin Aa, 1 adopts a groove binding conformation in
which it interacts mainly with residues G2, G3, G4, and
G5 (Figure 4A) on two neighboring strands. In particu-
lar, an H-bond is established between the carbonyl oxy-
gen of the ligand coumarin ring and the amino group of
G3, while the N-(2-hydroxyethyl)piperazinyl branch of 1
forms a salt–bridge and a water-mediated H-bond with the
phosphate group of G4 on the adjacent strand. The pres-
ence of this water-mediated interaction was further vali-
dated by 100 ns of unbiased MD simulation (Figure 4B),
during which the pose resulted stable. Furthermore, it is in-
teresting to note that in theAa pose the conformation of the
N-(2-hydroxyethyl)piperazinyl branch is stabilized by an in-
tramolecular H-bond between the 7-hydroxyl group of the
coumarin ring and the proximal nitrogen atom of the piper-
azinyl ring. Furthermore, residue T1 at the 5’ end points
down and stacks on the ligand aromatic scaffold establish-
ing favorable -stacking interactions. This pose is fully in
agreement with the NMR experiments showing a major in-
volvement of residues G2, G3, G4, and G5 in the bind-
ing of 1. In particular, the NMR spectra show a marked
variation of the protons chemical shifts of these guanines
in the presence of the ligand (36,41). Further evidence on
the involvement of these guanines in the binding of 1 comes
from additional NMR experiments that show the decrease
of the chemical shift variations of all the guanines when 1
is made to interact with mutated G-quadruplexes, namely,
[d(TGGBrGGT)]4 and [d(TGGGGBrT)]4 (41). In this case,
the presence of the bulky bromine atom inside the grooves
hampers the binding of 1. Finally, the “sandwich-like” con-
formation adopted by T1 in basin Aa (Figure 4A) is in line
with the involvement of this residue in the ligand binding
shown by the NMR studies (36,41). It is worth mentioning
that the Aa pose is similar to one of the two binding modes
5452 Nucleic Acids Research, 2014, Vol. 42, No. 9
Figure 4. (A) Representation of the binding FES of 1 to [d(TGGGGT)]4 with the lowest free-energy conformations shown as insets, Aa, Ab, and B. The
FES is represented as function of the POA and ψ CVs using isosurfaces of 1.5 kcal/mol. DNA is shown as gray sticks and cartoon, while the ligand is
shown as cyan sticks. K+ ions are depicted as purple spheres. Hydrogen bonds are represented as dashed black lines. Nonpolar hydrogens are omitted for
clarity. (B) Plots of the average rmsd of the heavy atoms of 1 during over 100 ns of MD simulation with the ligand in the Aa (upper), Ab (middle), and
B (lower) binding conformation as starting pose. Upper: the ligand binding mode Aa is very stable with a low average rmsd value (1.215 A˚) and all the
ligand/DNA interactions conserved along the whole simulation, including the water–bridge interaction between the ligand N-(2-hydroxyethyl)piperazinyl
branch and the phosphate group of G4. Middle: plot of the ligand rmsd in the binding modeAb relative to its initial pose (black line) and to theAa average
conformation (red line). The red plot shows that the Ab conformation changes in Aa after approximately 80 ns. Lower: the ligand binding mode at pose B
is very stable with a low average rmsd value (1.076 A˚) conserving all the ligand/DNA interactions during the whole simulation.
proposed in previous docking studies (Supplementary Fig-
ure S3) (41). However, few differences between the docking
pose andAa can be noticed. In particular, the docking bind-
ing mode is slightly shifted toward the 5’ end if compared
with Aa. In fact, at variance with Aa, in the pose predicted
by docking the N-(2-hydroxyethyl)piperazinyl group estab-
lishes favorable contacts with the phosphate group of G2
instead of that of G4. These differences mainly arise from
the fact that the docking algorithm used in this study does
not use an explicit solvent model and treats DNA as a rigid
body. Thus, water mediated interactions and DNA confor-
mational rearrangement to better accommodate the ligand
are not described. As a proof of concept, we redid the dock-
ing calculations with the same program using theDNA con-
formation found in minimum Aa (see ‘Materials andMeth-
ods’). In this test, the docking program finds the metady-
namics pose Aa to be one of the most favorable binding
modes (Supplementary Figure S4). These outcomes con-
firm the soundness of the previously reported bindingmode
of 1 but suggest at the same time to take exhaustively into
account the target flexibility and solvent effects when more
rigorous calculations on ligand binding are needed.
The second energy basin Ab (Figure 4A) corresponds to
another groove binding conformation in which the ligand
aromatic scaffold is slightly shifted toward the 3’ end. At
variance with Aa, in this pose, the sulfur atom of the ben-
zothiazole moiety H-bonds with the amino group of G3.
On the other hand, the N-(2-hydroxyethyl)piperazinyl es-
tablishes two polar contacts with the phosphate group of
G4 in a way comparable to Aa.
To verify the stability of the binding conformations of
basin Aa and Ab, over 100 ns unbiased MD simulations
were performed. StandardMDhas been indeed successfully
used to describe the interactions engaged by ligands locally
at the DNA binding site (70). In our simulations, the results
show a different behavior in the two cases. In particular, the
binding conformationAa is stable during the whole simula-
tion with low ligand rmsd values (Figure 4B), and conserves
all the ligand/DNA interactions. In contrast,Ab first main-
tains its original position in the binding site; then, after ap-
proximately 80 ns of simulation, it slightly moves toward
the 5’ end transforming in Aa. This finding is not totally
surprising since, looking at the FES in Figure 4A, the en-
ergy barrier that separates Ab from Aa is rather small, ap-
proximately 1.5 kcal/mol, and thus it can be overcome in
the standard MD time scale. This motion can be appreci-
ated looking at Figure 4B where the rmsd values of the lig-
and with respect to its position in the Aa conformation are
shown.
Furthermore, to investigate the G-quadruplex binding
selectivity of 1 toward duplex DNA, we performed dock-
ing calculations on a B-DNA structure (see ‘Materials and
Methods’). The docking results show that 1 binds to the
duplex minor groove similarly to what observed for G-
quadruplex (see Supplementary Discussion and Supple-
mentary Figure S5). These results confirm the experimen-
tal data showing that 1 is able to bind the duplex DNA,
Nucleic Acids Research, 2014, Vol. 42, No. 9 5453
interfering with the binding of the known B-DNA ligand
distamycin A (41). The structural information coming from
these computations can be exploited to developmore potent
and selective G-quadruplex ligands.
End-stacking
At variance with Aa and Ab where 1 shows groove binding
modes, in basinB, compound 1 lies at the 3’ end where it en-
gages favorable -stacking interactions with G5 and close
contacts with two neighboring thymine residues (T6; Figure
4A). However, the N-(2-hydroxyethyl)piperazinyl moiety
partially inserts into the groove interacting with the sugar-
phosphate backbone of DNA. In particular, the N4 atom of
the piperazinyl ring salt bridges with the phosphate group of
G5, while the hydroxyethyl group H-bonds with the phos-
phate of G4. It is worth mentioning that NMR data show a
marked chemical shift variation of T6–H6 and T6–methyl
protons in 1H NMR titrations on the 1/[d(TGGGGT)]4
complex (36,41), suggesting a role for T6 in the ligand bind-
ing. However, this residue is not involved in the previously
reported ligand bindingmodes, while these data are now for
the first time rationalized by our results.
The stability of this binding conformation was checked
running an over 100 ns unbiased MD simulation during
which the ligand bindingmode was stable conserving all the
ligand/DNA interactions (Figure 4B).
DNA-ligand binding free energy
The absolute ligand binding free energy (Gbind) can be
computed from the FES as the free-energy difference of the
system with the ligand in the bound and unbound state.
However, to obtain an accurate estimate of Gbind, a num-
ber of recrossing events between these two states should be
observed during the simulation (48). In our simulations, the
ligand visits several times both the bound (7.0 ≤ d ≤ 14.0
A˚) and the unbound states (24 < d < 26 A˚) as shown in
Supplementary Figure S6, leading to a quantitatively well-
characterized FES. At the end of the simulation, Gbind is
equal to –9.4 ± 1.4 kcal/mol. Unfortunately, experimental
data on the binding free energy of this ligand are not yet
available. However, the computed value falls in the range
from –9.0 to –11.0 kcal/mol, which are typically the exper-
imental Gbind values measured for lead compounds (71).
To provide a picture of the convergence of the binding
free-energy estimation, the free-energy difference between
the bound and unbound state was computed as a function
of the simulation time (Supplementary Figure S7). This fig-
ure shows that after 870 ns the free energy is converged. In
fact, for the rest of the simulation the free-energy difference
between bound and unbound states does not considerably
change, while the ligand continues visiting both the bound
and unbound states.
DISCUSSION
In the present study, we used metadynamics simulations
to study the binding process of 1 to the G-quadruplex
[d(TGGGGT)]4. From the metadynamics calculation, we
reconstructed the free-energy landscape of the ligand/DNA
binding process, estimating also the absolute DNA/ligand
binding free energy. We have thus identified the preferred
ligand binding sites on DNA associated with the lowest en-
ergy ligand binding modes. In particular, we have shown
that 1 interacts withG-quadruplex through a hopping bind-
ing mechanism passing from one DNA site to the other.
During this process the ligand assumes two lowest free-
energy binding modes, one to the groove and the other to
the 3’ end of the G-quadruplex. This is a peculiar binding
behavior with respect to other G-quadruplex ligands that
stimulates further experimental and theoretical investiga-
tions. For instance, in drug design one might exploit both
the binding modes, through a lead optimization procedure
of compound 1, to develop more potent and selective com-
pounds. Our study also shows that solvent and target flexi-
bility play an important role during the ligand binding and
neglecting such aspects might lead to inaccurate results. The
relevance of our results is enhanced by the fact that some of
the previously reported NMR data (41) are here for the first
time rationalized. For instance, we have shown that the T6
residue is involved in the 3’-end bindingmode, thus explain-
ing the experimental observations.
Our work is an example of fully unbiased binding study
of a ligand to DNAwhere no structural information on lig-
and binding is used. Here, metadynamics simulations are
applied for the first time to describe the ligand binding to
G-quadruplex. In our study, all the possible binding sites
on the DNA structure are visited and energetically evalu-
ated. Our findings confirm and well integrate the previously
reported experimental data, highlighting the importance of
using atomistic simulations to assist, complement, and ra-
tionalize experiments on biologically relevant phenomena.
The results, achieved at a relatively low computational cost,
render our protocol valuable for further investigations on
various forms of ligand/DNA interaction and useful even
formore automated drug discovery strategies to develop po-
tent and selective DNA ligands.
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